Eleonora Terzi

1.3k total citations
22 papers, 660 citations indexed

About

Eleonora Terzi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Eleonora Terzi has authored 22 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 13 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Eleonora Terzi's work include Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Disease and Transplantation (7 papers). Eleonora Terzi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Disease and Transplantation (7 papers). Eleonora Terzi collaborates with scholars based in Italy, Spain and United States. Eleonora Terzi's co-authors include Fabio Piscaglia, Luigi Bolondi, Sara Marinelli, Matteo Renzulli, Simona Leoni, Rita Golfieri, Alessandro Granito, Francesca Benevento, Emanuela Giampalma and Anna Pecorelli and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Hepatology.

In The Last Decade

Eleonora Terzi

21 papers receiving 645 citations

Peers

Eleonora Terzi

HEPAT

EPIDE

SURGE

PRM

PFM

Ali Habib United States

Naoya Kanogawa Japan

Vikki Tang China

Juxian Sun China

Taisuke Ueda Japan

Hiroaki Nagamatsu Japan

Chiara Cristofori Italy

Tianfu Wen China

Guoliang Shao China

Fumitoshi Hirokawa Japan

Ali Habib United States

Eleonora Terzi

611 ×1.2

HEPAT

302 ×1.0

EPIDE

347 ×2.1

SURGE

146 ×1.4

PRM

91 ×0.9

PFM

Citations per year, relative to Eleonora Terzi Eleonora Terzi (= 1×) peers Ali Habib

Countries citing papers authored by Eleonora Terzi

Since Specialization

Citations

This map shows the geographic impact of Eleonora Terzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Terzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Terzi more than expected).

Fields of papers citing papers by Eleonora Terzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Terzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Terzi. The network helps show where Eleonora Terzi may publish in the future.

Co-authorship network of co-authors of Eleonora Terzi

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Terzi. A scholar is included among the top collaborators of Eleonora Terzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Terzi. Eleonora Terzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Terzi, Eleonora, Massimo Iavarone, Simona Leoni, et al.. (2022). Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5). Cancers. 14(2). 336–336. 11 indexed citations

Terzi, Eleonora, Carmen Ayuso, Fabio Piscaglia, & Jordi Bruix. (2021). Liver Imaging Reporting and Data System: Review of Pros and Cons. Seminars in Liver Disease. 42(1). 104–111. 6 indexed citations

Cappelli, Alberta, Cristina Mosconi, Eleonora Terzi, et al.. (2018). Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage. European Journal of Nuclear Medicine and Molecular Imaging. 46(3). 661–668. 6 indexed citations

Terzi, Eleonora, Simona Leoni, Francesca Benevento, et al.. (2017). CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodules. Journal of Hepatology. 66(1). S208–S209. 3 indexed citations

Terzi, Eleonora, Simona Leoni, Francesca Benevento, et al.. (2017). CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodules. Digestive and Liver Disease. 49(1). e22–e22. 10 indexed citations

Terzi, Eleonora, Veronica Salvatore, Giulia Negrini, & Fabio Piscaglia. (2015). Ongoing challenges in the diagnosis of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology. 10(4). 451–463. 5 indexed citations

Granito, Alessandro, Sara Marinelli, Eleonora Terzi, et al.. (2015). Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure. Digestive and Liver Disease. 47(6). 518–522. 71 indexed citations

Terzi, Eleonora, et al.. (2015). Survival of patients with hepatocellular carcinoma (HCC) within the Bologna Liver Oncology Group: comparison with international guidelines. Digestive and Liver Disease. 47. e33–e33.

Golfieri, Rita, Cristina Mosconi, Alberta Cappelli, et al.. (2015). Efficacy of Radioembolization According to Tumor Morphology and Portal Vein Thrombosis in Intermediate–Advanced Hepatocellular Carcinoma. Future Oncology. 11(23). 3133–3142. 18 indexed citations

10.

Terzi, Eleonora, Fabio Piscaglia, Cristina Mosconi, et al.. (2014). TACE performed in patients with a single nodule of Hepatocellular Carcinoma. BMC Cancer. 14(1). 601–601. 43 indexed citations

11.

Leoni, Simona, Fabio Piscaglia, Ilaria Serio, et al.. (2014). Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group. Digestive and Liver Disease. 46(6). 549–555. 49 indexed citations

12.

Terzi, Eleonora, Laura Venerandi, Matteo Renzulli, et al.. (2014). The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series. Digestive Diseases. 32(6). 711–716. 45 indexed citations

13.

Terzi, Eleonora, W. Ray Kim, William Sánchez, et al.. (2014). Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transplantation. 21(2). 248–257. 19 indexed citations

14.

Piscaglia, Fabio, Eleonora Terzi, Alessandro Cucchetti, et al.. (2013). Treatment of hepatocellular carcinoma in Child-Pugh B patients. Digestive and Liver Disease. 45(10). 852–858. 31 indexed citations

15.

Marinelli, Sara, Alessandro Granito, Eleonora Terzi, et al.. (2013). Clinical predictors of response to sorafenib in patients with hepatocellular carcinoma.. Journal of Clinical Oncology. 31(15_suppl). e15149–e15149. 1 indexed citations

16.

Terzi, Eleonora, Rita Golfieri, Fabio Piscaglia, et al.. (2012). Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”. Journal of Hepatology. 57(6). 1258–1267. 118 indexed citations

17.

Cucchetti, Alessandro, Fabio Piscaglia, Matteo Cescon, et al.. (2012). Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients. Clinical Cancer Research. 18(16). 4397–4405. 68 indexed citations

18.

Bota, Simona, Fabio Piscaglia, Sara Marinelli, et al.. (2012). Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma. Liver Cancer. 1(3-4). 190–200. 75 indexed citations

19.

Cennamo, Vincenzo, Lorenzo Fuccio, Emanuela Giampalma, et al.. (2011). Choledochoscope-assisted percutaneous fibrin glue sealing of bile leak complicating transarterial chemoembolization of hepatocellular carcinoma after liver transplantation. Endoscopy. 43(S 02). E238–E239. 2 indexed citations

20.

Astegiano, M., et al.. (2006). Treatment of irritable bowel syndrome. A case control experience.. PubMed. 52(4). 359–63. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact